InsiderTrades.com logo
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
From Crypto Swap Profits   |   Ad
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Register for the FREE Workshop Now & get $10 in Bitcoin

LEXX Insider Trading

Insider Ownership Percentage: 26.40%
Insider Buying (Last 12 Months): $56,142.72
Insider Selling (Last 12 Months): $10,268.00

Lexaria Bioscience Insider Trading History Chart

This chart shows the insider buying and selling history at Lexaria Bioscience by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Lexaria Bioscience Share Price & Price History

Current Price: $2.41
Price Change: ▲ Price Increase of +0.04 (1.69%)
As of 12/9/2024 06:56 PM ET

This chart shows the closing price history over time for LEXX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
I was wrong. Dead wrong.
From Porter & Company   |   Ad
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Here’s the full story for you.

Lexaria Bioscience Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/2/2024Richard ChristopherCEOBuy22,828$2.24$51,134.7222,828View SEC Filing Icon  
8/12/2024Catherine C TurkelDirectorBuy1,600$3.13$5,008.003,100View SEC Filing Icon  
7/31/2024Vanessa CarleinsiderSell2,567$4.00$10,268.00View SEC Filing Icon  
2/9/2023Catherine C TurkelDirectorBuy1,500$2.84$4,260.001,500View SEC Filing Icon  
See Full Table
I was wrong. Dead wrong.
From Porter & Company   |   Ad
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Here’s the full story for you.

SEC Filings (Institutional Ownership Changes) for Lexaria Bioscience (NASDAQ:LEXX)

13.06% of Lexaria Bioscience stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at LEXX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Lexaria Bioscience Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2024Geode Capital Management LLC150,391$0.46M0.0%+31.0%0.951%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd18,626$57K0.0%+47.8%0.118%Search for SEC Filing on Google Icon
11/15/2024Invenomic Capital Management LP475,773$1.45M0.1%-7.4%3.007%Search for SEC Filing on Google Icon
11/15/2024HighTower Advisors LLC13,023$40K0.0%N/A0.082%Search for SEC Filing on Google Icon
8/15/2024Armistice Capital LLC1,020,000$2.84M0.0%N/A7.916%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC22,800$63K0.0%N/A0.177%Search for SEC Filing on Google Icon
5/16/2024Invenomic Capital Management LP473,265$1.72M0.1%-35.3%3.672%Search for SEC Filing on Google Icon
4/9/2024Welch Group LLC24,000$87K0.0%N/A0.194%Search for SEC Filing on Google Icon
2/14/2024Invenomic Capital Management LP731,981$0.92M0.0%-4.2%7.011%Search for SEC Filing on Google Icon
2/8/2024Cowen AND Company LLC256,327$0.32M0.1%N/A2.455%Search for SEC Filing on Google Icon
11/15/2023Armistice Capital LLC889,272$0.89M0.0%N/A10.992%Search for SEC Filing on Google Icon
8/14/2023Invenomic Capital Management LP766,573$0.56M0.0%+62.0%9.476%Search for SEC Filing on Google Icon
8/8/2022Merit Financial Group LLC21,267$63K0.0%N/A0.357%Search for SEC Filing on Google Icon
2/11/2022Invenomic Capital Management LP359,113$1.45M0.3%+1.9%6.034%Search for SEC Filing on Google Icon
11/15/2021MD Financial Management Inc.407,687$2.55M0.1%+15,078.2%7.988%Search for SEC Filing on Google Icon
8/16/2021Invenomic Capital Management LP317,110$2.22M0.5%+7.1%6.213%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC17,200$0.12M0.0%N/A0.337%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC50,385$0.35M0.0%N/A0.987%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.25,976$0.18M0.0%N/A0.509%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC14,915$84K0.0%N/A0.292%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC14,915$84K0.0%N/A0.292%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Lexaria Bioscience logo
Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods. The company's DehydraTECH is used with a range of active molecules encompassing fat-soluble vitamins, pain medications, hormones, PDE5 inhibitors, antivirals, oral nicotine and its analogs, and cannabinoids. Its DehydraTECH technology evaluates therapeutic indications, including hypertension, heart disease, and diabetes; and is suitable for a variety of product formats, such as pharmaceuticals, nutraceuticals, over the counter, and consumer packaged goods. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.
Read More on Lexaria Bioscience

Today's Range

Now: $2.41
Low: $2.34
High: $2.53

50 Day Range

MA: $2.54
Low: $2.01
High: $3.31

52 Week Range

Now: $2.41
Low: $1.20
High: $6.85

Volume

125,996 shs

Average Volume

262,331 shs

Market Capitalization

$42.05 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.99

Who are the company insiders with the largest holdings of Lexaria Bioscience?

Lexaria Bioscience's top insider investors include:
  1. Richard Christopher (CEO)
  2. Catherine C Turkel (Director)
  3. Vanessa Carle (Insider)
Learn More about top insider investors at Lexaria Bioscience.

Who are the major institutional investors of Lexaria Bioscience?

Lexaria Bioscience's top institutional shareholders include:
  1. Invenomic Capital Management LP — 3.01%
  2. Geode Capital Management LLC — 0.95%
  3. XTX Topco Ltd — 0.12%
  4. HighTower Advisors LLC — 0.08%
Learn More about top institutional investors of Lexaria Bioscience stock.

Which institutional investors are selling Lexaria Bioscience stock?

During the previous quarter, LEXX stock was sold by these institutional investors:
  1. Invenomic Capital Management LP

Which institutional investors are buying Lexaria Bioscience stock?

Within the last quarter, LEXX stock was purchased by institutional investors including:
  1. Geode Capital Management LLC
  2. HighTower Advisors LLC
  3. XTX Topco Ltd
In the previous year, these company insiders have bought Lexaria Bioscience stock:
  1. Richard Christopher (CEO)
  2. Catherine C Turkel (Director)
Learn More investors buying Lexaria Bioscience stock.
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
From Crypto Swap Profits   |   Ad
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Register for the FREE Workshop Now & get $10 in Bitcoin